US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on April 22 for "Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins" (Maryland, Massachusetts Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,336, issued on April 22, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins" was invented by Gary J. Nabel (Chestnut Hill, Mass.), Wataru Akahata (Kensington, Md.) and Srinivas Rao (Columbia, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention features compositions and methods for the prevention or treatment of one or more strains of Chikungunya virus, as well as other alphavirus-mediated diseases."

The patent was filed on May 27, 2024, under Applicat...